Filter
1810
Filtered Results: 1810
Text search:
immunity
Featured
Recommendations
196
New Publications
412
Language
Document type
No document type
866
Guidelines
315
Studies & Reports
281
Fact sheets
100
Manuals
79
Strategic & Response Plan
69
Training Material
38
Situation Updates
19
Brochures
11
Infographics
10
Resource Platforms
9
Videos
9
Online Courses
4
Countries / Regions
Global
77
India
74
Congo, Democratic Republic of
43
Germany
41
Latin America and the Carribbean
34
Kenya
33
Syria
30
Africa
30
Nigeria
28
South Africa
28
Myanmar / Burma
24
Senegal
23
Ethiopia
21
Rwanda
20
Tanzania
20
West and Central Africa
20
Western and Central Europe
20
Middle East and North Africa
19
Brazil
19
Haiti
17
Bangladesh
17
Burkina Faso
16
Venezuela
16
East and Southern Africa
16
Sierra Leone
15
Ghana
13
Malawi
13
Uganda
13
South Sudan
13
Liberia
13
Nepal
12
Ukraine
12
Russia
12
Yemen
12
South–East Asia Region
11
Namibia
11
Cameroon
10
Eastern Europe
10
Central African Republic
10
Zimbabwe
9
Philippines
9
Mozambique
9
Zambia
9
Lesotho
8
Benin
8
Mali
8
Somalia
8
Pakistan
8
Afghanistan
7
Guinea
7
Cambodia
6
Côte d’Ivoire / Ivory Coast
6
Lebanon
6
Vietnam
6
Madagascar
6
China
5
Argentina
5
Indonesia
5
Niger
4
Morocco
4
Italy
4
Asia
4
Luxembourg
4
France
4
Colombia
3
Thailand
3
Kazakhstan
3
Chile
3
Peru
3
United Kingdom
3
Spain
3
Angola
3
Chad
3
Botswana
3
Iraq
3
Eswatini/ Swaziland
3
Mexico
2
Turkey
2
Togo
2
Albania
2
Laos
2
Congo-Brazzaville
2
Armenia
2
Jordan
2
Saudi Arabia
2
Western Pacific Region
2
Tunisia
2
Papua New Guinea
2
Sudan
2
Libya
2
Ecuador
2
Guatemala
2
North Macedonia
1
North Korea
1
Switzerland
1
Timor Leste/ East Timor
1
El Salvador
1
Iran
1
Canada
1
Singapore
1
Burundi
1
Malaysia
1
Qatar
1
Mauritania
1
USA
1
Dominican Republic
1
Guinea-Bissau
1
Paraguay
1
North America
1
Japan
1
Belgium
1
Mauritius
1
Portugal
1
South Korea
1
Belarus
1
Israel
1
Latvia
1
Bolivia
1
Nicaragua
1
Sri Lanka
1
Djibouti
1
Egypt
1
Greece
1
Palestine
1
Georgia
1
Honduras
1
Bhutan
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
610
Clinical Guidelines
216
Women & Child Health
102
Public Health
86
Key Resources
78
Pharmacy & Technologies
23
Capacity Building
22
Annual Report MEDBOX
1
Toolboxes
COVID-19
369
TB
114
Rapid Response
106
HIV
93
NTDs
82
Mental Health
57
Refugee
57
Conflict
50
Polio
49
Ebola & Marburg
44
Planetary Health
38
Cholera
27
AMR
27
Zika
26
Caregiver
23
Disability
22
Global Health Education
21
NCDs
15
Health Financing Toolbox
11
Natural Hazards
10
Pharmacy
9
Specific Hazards
4
Social Ethics
4
Malaria
4
South Sudan
1
Typhoon
1
10 May 2021
This scientific brief replaces the WHO Scientific Brief entitled “’Immunity passports’ in the context of COVID-19”, published 24 April 2020.
This update is focused on what is currently understood about SARS-CoV-2 immunity from natural infection. More information about considera...
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt...
As new variants emerge people are wondering if they should wait until a more efficacious vaccine is available or if they should go ahead and get vaccinated now? Answering your questions on COVID-19 vaccines and variants in this episode of Science in 5 is WHO's Dr Soumya Swaminathan.
The Lancet, Early Online Publication, 11 July 2014
doi:10.1016/S0140-6736(14)60934-X
*Free registration is required to view this article
Document d’information scientifique
24 avril 2020
Le développement d’une immunité face à un agent pathogène à la suite d’une infection naturelle comporte plusieurs étapes et prend généralement une à deux semaines. Une infection virale entraîne immédiatement une réponse immunit...
Herd immunity by mass vaccination offers the potential to substantially limit the continuing spread of COVID-19, but high levels of vaccine hesitancy threaten this goal. In a cross-country analysis of vaccine hesitant respondents across Latin America in January 2021, we experimentally tested how fiv...
Natural immunity against COVID-19
Scientific report 10 May 2021
Vaccines are designed to give you immunity without the dangers of getting the disease. It’s common to experience some mild to moderate side effects when receiving vaccinations. This is because your immune system instructs your body to increase blood flow so more immune cells can circulate, and it ...
Les vaccins sont conçus pour vous conférer une immunité sans les dangers d’avoir contracté la maladie. Il est courant de ressentir quelques effets indésirables légers à modérés après avoir reçu un vaccin. Ils sont dus au fait que votre système immunitaire demande à votre organisme d'a...
COVID-19 vaccine hesitancy is currently one of the main obstacles to worldwide herd immunity and socioeconomic recovery. Because vaccine coverage can vary between and within countries, it is important
to identify sources of variation so that policies can be tailored to different population groups. ...
Elderly people are at a higher risk of COVID-19 infection due to their decreased immunity and body reserves, as well as multiple associated comorbidities like diabetes, hypertension, chronic kidney disease and chronic obstructive pulmonary disease. Also, course of disease tends to be more severe in ...
26 March 2021 Slideset updated regularly to include the latest data on the evolution and duration of COVID-19 symptoms and prevalence and duration of natural immunity.
Vaccines contribute to the battle against antimicrobial resistance (AMR) by preventing infections and thereby reducing antimicrobial use and the incidence of disease from resistant pathogens. By preventing infection transmission, vaccines extend population protection by also reducing the risk of inf...
One health Response to AMR Containment.
In a significant move for the public health sector, Kerala has become the first state in India to launch an action plan to combat the growing cases of antimicrobial immunity, arising primarily from irrational use of medicines and excessive antibiotics used in...
Since the release of the first volume in May 2020, the COVID-19 pandemic has continued to rage around the world. By mid-March, 2021, countries around the globe had reported over 123 million cases—a nearly five-fold increase since this report’s previous volume—and over 2.7 million deaths attrib...
WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following the successful roll-out of this vaccine, epidemics due to Neisseria meningitidis serogroup A (NmA) are...
The backsliding of immunization coverage during the COVID-19 pandemic, combined with delayed catch-up efforts has resulted in a large and growing immunity gap. There is an urgent need to close this gap, and enable millions of missed children to be vaccinated. The Essential Immunization Recovery Plan...
COVID-19 is a pandemic that is currently ravaging the world. Infection rate is steadily increasingin Sub-Saharan Africa. Pregnant women and their infants may suffer severe illnesses due to theirlower immunity. This guideline prepares and equips clinicians working in the maternal and new-born section...
There are currently 4 different serotypes of Dengue virus known to science. Each time someone get infected and recovers, the individual will be protected by a lifelong immunity from further infection against that specific serotype and that serotype only.
Consequent infection from different serotype...
